Benjamin F. Edwards & Company’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$3K Hold
400
﹤0.01% 1985
2024
Q1
$3K Sell
400
-243
-38% -$1.61K ﹤0.01% 1961
2023
Q4
$4K Sell
643
-300
-32% -$1.69K ﹤0.01% 1898
2023
Q3
$5K Sell
943
-175
-16% -$1.17K ﹤0.01% 1552
2023
Q2
$6K Sell
1,118
-157
-12% -$845 ﹤0.01% 1501
2023
Q1
$8K Sell
1,275
-1,532
-55% -$8.54K ﹤0.01% 1444
2022
Q4
$13K Sell
2,807
-1,000
-26% -$4.93K ﹤0.01% 1373
2022
Q3
$18K Hold
3,807
﹤0.01% 1280
2022
Q2
$23K Sell
3,807
-2,942
-44% -$32.7K ﹤0.01% 1210
2022
Q1
$130K Sell
6,749
-2,282
-25% -$52.3K 0.01% 805
2021
Q4
$295K Buy
9,031
+3,029
+50% +$122K 0.01% 581
2021
Q3
$246K Buy
6,002
+857
+17% +$31.1K 0.01% 608
2021
Q2
$185K Buy
5,145
+1,908
+59% +$70.4K 0.01% 667
2021
Q1
$126K Buy
+3,237
New +$146K 0.01% 786
2020
Q4
Sell
-150
Closed -$8K 1652
2020
Q3
$8K Buy
+150
New +$7.94K ﹤0.01% 1325

Other funds holding GDRX

Benjamin F. Edwards & Company's GDRX Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its GoodRx Holdings (GDRX) position steady in Q2 2024 at 400 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Benjamin F. Edwards & Company first reported a position in GDRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $295K in Q4 2021. 165 funds tracked by Wall St. Rank hold GDRX as of Q2 2024.

  • Benjamin F. Edwards & Company held 400 shares of GoodRx Holdings worth $3K as of Q2 2024.
  • Benjamin F. Edwards & Company left its GoodRx Holdings share count unchanged in Q2 2024.
  • GoodRx Holdings made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1985 holding.
  • Benjamin F. Edwards & Company first reported a position in GoodRx Holdings in Q3 2020 and has held it in 15 quarters since.
  • Benjamin F. Edwards & Company's GoodRx Holdings position peaked at $295K in Q4 2021.
  • 165 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.